Tag archive for ‘Michael Shields’
By news On Wednesday, April 25th, 2018
0 Comments

Novartis’ digital drive continues with eye-disease app

(adsbygoogle = window.adsbygoogle || []).push({}); ZURICH (Reuters) – Novartis’s foray into digital technology intensified on Wednesday as the Swiss drugmaker launched a mobile-phone based More...

By news On Monday, April 16th, 2018
0 Comments

Givaudan turns to Haitian roots for anti-wrinkle ingredient

ZURICH (Reuters) – Swiss fragrance and flavors company Givaudan has begun recycling Haitian vetiver roots now used to make oil for fragrances to produce a new cosmetic substance it said can reduce wrinkles More...

By news On Friday, March 23rd, 2018
0 Comments

Novartis touts U.S. filing plans for MS drug as patent losses loom

ZURICH (Reuters) – Novartis plans to file its BAF312 multiple sclerosis drug for U.S. approval within weeks, the Swiss drugmaker said on Friday, as it seeks to refresh its portfolio of neurological medicines More...

By news On Wednesday, March 7th, 2018
0 Comments

Novartis, U.S. partner plan remote trials to boost participation

ZURICH (Reuters) – Novartis plans up to 10 clinical trials over three years using a U.S. partner’s mobile technology to help free patients from burdensome hospital trips as the Swiss drugmaker aims to More...

By news On Tuesday, February 27th, 2018
0 Comments

Swiss social network ASMALLWORLD plans listing

ZURICH (Reuters) – ASMALLWORLD AG plans to list on the SIX Swiss Exchange within weeks, the private social network operator said on Tuesday. The Zurich-based company generates revenue primarily through annual More...

By news On Monday, February 19th, 2018
0 Comments

Collect some uranium glass for that peaceful glow

ZURICH (Reuters) – Uranium glass occupies a little-known niche in the collectables world, whose members appreciate its soft color and distinctive glow, which comes from the uranium added as the glass was More...

By news On Friday, January 26th, 2018
0 Comments

Roche wins EU panel’s recommendation for hemophilia drug

ZURICH (Reuters) – A European Union panel on Friday recommended approval of Roche’s Hemlibra to treat hemophilia in some patients after the Swiss drugmaker got the green light last year to begin selling More...

By news On Friday, January 12th, 2018
0 Comments

Roche’s star MS medicine Ocrevus wins EU approval

ZURICH (Reuters) – The European Union approved Roche’s multiple sclerosis medicine Ocrevus, one the Swiss company’s key new drugs that likely neared $1 billion in revenue in its first nine months on More...

By news On Friday, December 15th, 2017
0 Comments

FIFA watchdog bans Brazilian soccer chief Del Nero for 90 days

ZURICH (Reuters) – FIFA’s ethics watchdog has provisionally banned Marco Polo Del Nero, the head of Brazil’s soccer association, for 90 days, the organization said on Friday. Del Nero has been banned More...

By news On Monday, December 11th, 2017
0 Comments

Three more Russian athletes file doping appeals: sport court

ZURICH (Reuters) – The Court of Arbitration for Sport said on Monday three more Russian athletes — champion biathlete Olga Zaytseva and cross country skiers Yulia Chekaleva and Anastasia Dotsenko — More...